교수진 소개
- Name
- Won Young CHOI, M.D., Ph.D.
- Faculty Appointment
(title, department)
- Associate professor, Department of Cancer Biomedical Science
Staff physician, National Cancer Center Hospita
Research Scientist, Research Institute
- Area of Expertise
- Medical Oncology, Molecular biology, Translational research
- E-mail
- wonyoungchoi@gmail.com
- Work Experience
- Oct 2020 - : Staff Physician / Research Scientist, National Cancer Center
Mar 2019 – Sep 2020: Clinical Staff, National Cancer Center
Mar 2018 – Feb 2019: Clinical Fellow, Chonnam National University Hwasun Hospital
- Educational Background
- Mar 2014 – Feb 2018: Ph.D., KAIST
Mar 2010 – Aug 2012: M.S. Chonnam National University
Mar 2003 – Feb 2009: M.D. Chonnam National University
- Research Interests (Please place in paragraph form)
-
Novel therapeutic approaches for solid tumors
Mechanistic studies of chemotherapy resistance
Clinical trials
- International Collaboration
-
- Achievements
-
2022 SCI-E A Comprehensive and Comparative Review of Global Gastric Cancer Treatment Guidelines: JOURNAL OF GASTRIC CANCER. 22(1):3~23 (3.197)
2022 SCI-E Therapeutic Targeting of DNA Damage Response in Cancer: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 23(3):1701~ (6.208)
2021 SCI-E Plasma complement C7 as a target in non-small cell lung cancer patients to implement 3P medicine strategies: EPMA JOURNAL. 12:629~645 (6.543)
2021 SCI-E Genomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study: CANCERS. 13(21):5466~ (6.639)
2021 SCI-E The Clinical Impact of Capmatinib in the Treatment of Advanced Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutation or Gene Amplification: CANCER RESEARCH AND TREATMENT. Online:Published (4.679)
2020 기타 Case Report: Good responsiveness of metastatic sarcomatoid urothelial carcinoma with chondrosarcomatous differentiation to immune checkpoint inhibitor after radical surgery and adjuvant chemotherapy: f1000research journal. 9:1458~ (0)
2020 SCI-E YAP and AP-1 Cooperate to Initiate Pancreatic Cancer Development from Ductal Cells in Mice: CANCER RESEARCH. 80(21):4768~4779 (9.727)
2020 SCI-E A nanowire-based liquid biopsy method using cerebrospinal fluid cell-free DNA for targeted management of leptomeningeal carcinomatosis: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. Online:Published (3.656)
2020 SCI-E Ceritinib-Induced Organizing Pneumonia in Lung Cancer: A Retrospective Analysis: TARGETED ONCOLOGY. 15(4):513~522 (4.036)
2019 SCI-E Gal-3BP Negatively Regulates NF-kB Signaling by Inhibiting the Activation of TAK1: FRONTIERS IN IMMUNOLOGY. Online:Published (4.716)
2019 SCI-E Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled Trial: CANCER RESEARCH AND TREATMENT. Online:Published (3.363)
2018 SCI YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC: CANCER RESEARCH. 78(12):3306~3320 (9.13)
2017 SCI Hippo effector YAP directly regulates the expression of PD-L1 transcripts in EGFR-TKI-resistant lung adenocarcinoma: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 491(2):493~499 (2.466)
2014 SCI-E Rapidly progressing primary splenic angiosarcoma with fatal hemorrhagic event: Journal of Chemotherapy. : (1.604)
2013 SCI-E Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer: BMC CANCER. : (3.319)
2013 SCI-E Clinical Prognostic Factors for Locally Advanced Esophageal Squamous Carcinoma Treated after Definitive Chemoradiotherapy: CANCER RESEARCH AND TREATMENT. : (2.975)
2012 SCI Drug Rash Induced by Levothyroxine Tablets: Thyroid. : (3.544)
2012 기타 A Case of Cardiogenic Shock after Chemotherapy with 5-Fluorouracil and Leucovorin in Rectal Cancer: The Korean Journal of Medicine. : ()
2011 기타 Two Cases of Neuroendocrine Carcinoma and GIST in a Patient with Neurofibromatosis Type 1: The Korean Journal of Medicine. : ()
